UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037997
Receipt number R000043313
Scientific Title Effect of mailed outreach invitation for a 75 g oral glucose tolerance test in women with previous gestational diabetes
Date of disclosure of the study information 2020/01/01
Last modified on 2019/09/12 11:13:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of mailed outreach invitation for a 75 g oral glucose tolerance test in women with previous gestational diabetes

Acronym

Effect of mailed outreach invitation for a 75 g oral glucose tolerance test in women with previous gestational diabetes

Scientific Title

Effect of mailed outreach invitation for a 75 g oral glucose tolerance test in women with previous gestational diabetes

Scientific Title:Acronym

Effect of mailed outreach invitation for a 75 g oral glucose tolerance test in women with previous gestational diabetes

Region

Japan


Condition

Condition

Gestational diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether mailing a letter for outreach invitation to women with a history of gestational diabetes is become a recommendation for a 75 g oral glucose tolerance test as a postpartum glucose tolerance assessment

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Proportion of women achieving a 75 g OGTT

Key secondary outcomes

1. Proportion of a 75 g OGTT abnormal (Borderline type or diabetic type).
75gOGTT results are based on diabetes diagnostic criteria,
(i) Diabetic type: fasting plasma glucose level of more than 126 mg/dl or 2-h value of more than 200 mg/dl in 75gOGTT.
(ii)Normal type; fasting plasma glucose level of<110 mg/dl and 2-h value of<140mg/dl in OGTT.
(iii) Borderline type (neither diabetic nor normal type); falling between the diabetic and normal values.
2.Comparison of AUC-glucose, AUC-IRI, HOMA-IR, and Insulinogenic index during the OGTT calculated at 3 months after delivery.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine Behavior,custom

Interventions/Control_1

Mail a letter for outreach invitation to women with a history of gestational diabetes and perform a 75 g OGTT to the applicants.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Inclusion criteria:
1. Women with a history of GDM who underwent glycemic control during the pregnancy in our hospital
2. Normal glucose tolerance was confirmed by a 75 g OGTT at 3 months after delivery
3. More than one year after delivery
4. No appointment for the next visit

Key exclusion criteria

Exclusion criteria:
1. Chronic or severe illnesses that the investigator judges to be difficult to perform
2. During pregnancy
3. Having already been diagnosed with diabetes

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Tanaka

Organization

St.Marianna University School of Medicine

Division name

Division of Metabolism and Endocrinology,Department of Internal Medicine

Zip code

216-8511

Address

2-16-1 Sugao,Miyamae-ku,Kawasaki,Kanagawa 216-8511,Japan

TEL

0449778111

Email

smu.tainai@gmail.com


Public contact

Name of contact person

1st name Kana
Middle name
Last name Igarashi

Organization

St.Marianna University School of Medicine

Division name

Division of Metabolism and Endocrinology,Department of Internal Medicine

Zip code

216-8511

Address

2-16-1 Sugao,Miyamae-ku,Kawasaki,Kanagawa 216-8511,Japan

TEL

0449778111

Homepage URL


Email

k2igarashi@marianna-u.ac.jp


Sponsor or person

Institute

St.Marianna University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

St.Marianna University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board,St.Marianna University School of Medicine

Address

2-16-1 Sugao,Miyamae-ku,Kawasaki,Kanagawa 216-8511,Japan

Tel

0449778111

Email

k-sienbu.mail@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖マリアンナ医科大学病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 09 Month 12 Day

Date of IRB


Anticipated trial start date

2019 Year 09 Month 24 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 09 Month 12 Day

Last modified on

2019 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043313